[1]郑加涛,王旭初,苏冬冬.四子种王胶囊联合西药治疗弱畸精症疗效及对患者抗苗勒管激素、抑制素B的影响[J].陕西中医,2022,(1):45-48.[doi:DOI:10.3969/j.issn.1000-7369.2022.01.010]
　ZHENG Jiatao,WANG Xuchu,SU Dongdong.The therapeutic effect of Sizi Zhongwang capsule with western medicine in treating oligo-astheno-teratospermia and its effect on AMH and INHB content[J].,2022,(1):45-48.[doi:DOI:10.3969/j.issn.1000-7369.2022.01.010]
点击复制

四子种王胶囊联合西药治疗弱畸精症疗效及对患者抗苗勒管激素、抑制素B的影响
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2022年1期
页码:
45-48
栏目:
临床研究
出版日期:
2022-01-05

文章信息/Info

Title:
The therapeutic effect of Sizi Zhongwang capsule with western medicine in treating oligo-astheno-teratospermia and its effect on AMH and INHB content
作者:
郑加涛; 王旭初; 苏冬冬
(河北省沧州中西医结合医院生殖医学科,河北 沧州 061001)
Author(s):
ZHENG Jiatao; WANG Xuchu; SU Dongdong
(Department of Reproductive Medicine,Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine,Cangzhou 061001,China)
关键词:
弱畸精症;  四子种王胶囊;  抗苗勒管激素;  抑制素B;  畸形率;  性功能障碍
Keywords:
Oligo-astheno-teratospermia;  Sizi Zhongwang capsule;  Anti-Mü; llerian hormone;  Inhibin B;  Malformation rate;  Sexual dysfunction
分类号:
R 698.2
DOI:
DOI:10.3969/j.issn.1000-7369.2022.01.010
文献标志码:
A
摘要:
目的:探讨四子种王胶囊辅助西药治疗弱畸精症疗效及对患者抗苗勒管激素(AMH)、抑制素B(INHB)的影响。方法:选取弱畸精症患者180例,依据治疗方式不同分为对照组和研究组,各90例。对照组给予常规西药,研究组在对照组基础上给予四子种王胶囊治疗,两组均治疗3个月。统计两组治疗效果、不良反应及治疗前、治疗1个月、3个月后精子密度、活动率、畸形率、精子活动力(慢速直线运动、快速直线运动、原地不动)、精浆AMH、血清INHB含量、性功能障碍(IIEF-5)。结果:研究组治疗总有效率为83.33%高于对照组的70.00%(P<0.05)。治疗3个月后研究组精子密度、活动率高于对照组,畸形率低于对照组(P<0.05)。治疗3个月后研究组精子原地不动数量低于对照组,慢速直线运动及快速直线运动数量高于对照组(P<0.05)。治疗1个月、3个月后研究组AMH、INHB含量高于对照组(P<0.05)。治疗前、治疗1个月、3个月后两组IIEF-5评分比较,差异无统计学意义(P>0.05)。两组不良反应发生率比较,差异无统计学意义(P>0.05)。结论:四子种王胶囊辅助西药治疗弱畸精症疗效显著,有助于上调AMH、INHB,降低精子畸形率,提高精子活率及活动力,且安全性较高。
Abstract:
Objective:To investigate the effect of Sizi Zhongwangwang capsules on western medicine in the treatment of oligo-astheno-teratospermia and the effect of anti-Müllerian hormone(AMH)and inhibin B(INHB)content.Methods:180 patients with oligo-astheno-teratospermia were selected according to simple randomization,90 cases in each group.The control group was given conventional western medicine,and the experimental group was given Sizi Zhongwangwang capsules based on the control group,all treated for 3 months.The treatment effect,adverse reactions and sperm density,activity rate,deformity rate,sperm motility(slow linear motion,fast linear motion,in situ),seminal plasma AMH,serum INHB content,and sexual dysfunction(IIEF-5)before treatment,1 month and 3 months after treatment were counted in both groups.Results:The total effective rate of treatment in the experimental group was 83.33% higher than that in the control group(70.00%,P<0.05).After 3 months of treatment,the sperm density and activity rate of the experimental group were higher than the control group,and the deformity rate was lower than the control group(P<0.05).After 3 months of treatment,the number of sperm immobilization in the experimental group was lower than that of the control group,and the number of slow linear motion and fast linear motion was higher than that of the control group(P<0.05).After 1 month and 3 months of treatment,the content of AMH and INHB in the experimental group was higher than that in the control group(P<0.05).There was no significant difference in IIEF-5 scores between the two groups before treatment,1 month and 3 months after treatment(P>0.05).There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion:Sizi Zhongwang capsule assisted western medicine in the treatment of oligo-astheno-teratospermia has a significant effect,which helps to increase AMH and INHB,reduce the rate of sperm deformity,improve sperm viability and motility,and has high safety.

参考文献/References:

[1] Ji J,Xu M,Huang Z,et al.Mitochondrial dna sequencing and large-scale genotyping identifies mt-nd4 gene mutation associated with idiopathicoligo as the nospermia[J].Oncotarget,2017,8(32):52975-52982.
[2] Xie C,Ping P,Ma Y,et al.Correlation between methylenetetrahydrofolate reductase gene polymorphism and oligoasthenospermia and the effects of folic acid supplementation on semen quality[J].Transl Androl Urol,2019,8(6):678-685.
[3] 贾丽娜.李祥云教授治疗精子DNA损伤性不育经验[J].陕西中医,2020,41(1):89-91.
[4] 康雪冰.硫酸锌联合甲钴胺治疗糖尿病周围神经病变的临床观察[J].实用临床医药杂志,2017,21(11):48-50,80.
[5] 刘艳君,贾婵维.抑制素B和抗苗勒管激素检测在辅助生殖技术中的应用[J].中华检验医学杂志,2017,40(3):158-161.
[6] 王天琪,苑丽华,撒元红,等.抗苗勒氏管激素与男性生殖内分泌相关疾病研究进展[J].基础医学与临床,2018,38(3):405-408.
[7] 孙 文.不同方式精索静脉曲张结扎术对患者精液质量的影响及安全性研究[J].陕西医学杂志,2019,48(10):1292-1294,1304.
[8] 国家中医药管理局.中医病证诊断疗效标准[M].北京:中国医药科技出版社,2016:192.
[9] 李鹏程,陈 鑫,朱晓博,等.低能量体外冲击波治疗阴茎硬结症初步探讨(附32例报告)[J].中华男科学杂志,2018,24(4):340-344.
[10] Castellana G,Carone D.Microlithiasis of seminal vesicles and severe oligoasthenospermia in pulmonary alveolar microlithiasis(pam):Report of an unusual sporadic case[J].Int J Fertil Steril,2015,9(1):137-140.
[11] 郭小芳,文 希,李 平,等.二甲双胍片与硫酸锌片联合治疗对多囊卵巢综合征患者内分泌功能的影响[J].中国医院用药评价与分析,2017,17(4):474-476.
[12] 张利平,呼改琴,周艳红,等.蛋白琥珀酸铁联合维生素C治疗对妊娠合并缺铁性贫血孕妇铁调素、促红细胞生成素的影响[J].中国妇幼保健,2018,33(11):2442-2445.
[13] Davis SM,Lahlou N,Cox-Martin M,et al.Gonadal function is associated with cardiometabolic health in prepubertal boys with klinefelter syndrome[J].J Clin Endocrinol Metab,2018,103(9):3449-3455.
[14] 张争强,武洛洛,刘宗昆,等.豁痰化瘀补肾汤治疗弱精、少精症之经验总结[J].影像研究与医学应用,2017,1(9):175-177.
[15] 马紫阳,任飞强,杨雪梅,等.中医辨证治疗阳痿研究进展[J].陕西中医,2021,42(3):402-404.
[16] 赵海燕,徐 华,辛增莲,等.血清抑制素B在新疆维、汉族男性不育症中的研究[J].标记免疫分析与临床,2018,25(9):1265-1267,1304.
[17] 王 磊,高 明,刘 项,等.不同来源精子治疗完全性弱精子症妊娠结局研究[J].陕西医学杂志,2020,49(2):148-150,161.
[18] 武卫党,慈小燕.淫羊藿苷元对临床重要药物转运体抑制作用研究[J].药物评价研究,2018,41(6):56-61.
[19] 刘 倩,余 意.枸杞子活性成分及分析方法研究进展[J].辽宁中医药大学学报,2018,20(11):56-59.
[20] 邹家丽,李安遥,王启铭,等.归肾经补阳药的网络药理学机制研究[J].中草药,2019,50(8):1838-1847.

备注/Memo

备注/Memo:
基金项目:河北省中医药管理局科研计划项目(2018486)
更新日期/Last Update: 2022-01-09